[LGND] QoQ Quarter Result on 31-Dec-2012 [#Q4]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
14-Mar-2013
Financial Year
2012
Quarter
31-Dec-2012 [#Q4]
Profit Trend
QoQ- 647.94%
YoY- -80.68%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Revenue 13,005 9,580 11,651 13,635 6,375 5,742 5,636 74.53%
PBT 2,025 3,804 1,370 950 -52 -3,728 -522 -
Tax 60 110 66 -1,636 142 338 -35 -
NP 1,965 6,091 1,495 1,063 -194 -2,267 1,133 44.30%
Tax Rate -2.96% -2.89% -4.82% 172.21% - - - -
Total Cost 11,040 3,489 10,156 12,572 6,569 8,009 4,503 81.72%
Ratio Analysis
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
NP Margin 15.11 63.58 12.83 7.80 -3.04 -39.48 20.10 -17.30%
Per Share
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
EPS 0.10 0.30 0.07 0.05 -0.01 -0.11 0.07 26.81%
EPS Diluted 0.09 0.30 0.07 0.05 -0.01 -0.11 0.07 18.22%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.